drugset / Trial / NCT00028782

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

NCT00028782 ↗

Terminated 80 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelDiagnostic

Summary

This phase II trial is studying how well EF5 works in detecting oxygen level and blood vessels in tumor cells of patients who are undergoing photodynamic therapy for intraperitoneal or pleural cancer. Diagnostic procedures using EF5 to detect oxygen level and blood vessels in tumor cells may help to improve the way photodynamic therapy is given

Timeline

Start
2001-10
Primary completion
2007-09
Completion
—

Outcome

Outcome not reported

Stopped: “Administratively complete.”

Drugs

EvaluationDrugModalityDoseRoute
Subject etanidazole Small molecule — Intravenous